A Distinct Approach to Clinical GenAI Oversight

Fabio A. Thiers and Kimberly Lucy
Additional contact information
Fabio A. Thiers: Convergen AI

No vm6zy_v1, OSF Preprints from Center for Open Science

Abstract: Policymakers are determined to regulate clinical Generative AI (GenAI) solutions, but progress has been hampered by the commingling with regulatory approaches originally designed for Narrow AI (NarAI). This article clarifies this matter by describing the distinctive function and risk profile of GenAI models in healthcare settings. It elaborates why regulatory frameworks crafted for NarAI oversight are not adequate for GenAI because of their distinct nature. A first principle analysis is then used to delineate the pivotal role that healthcare organizations will need to take in GenAI oversight. Finally, it describes a distinct approach to clinical GenAI regulation that combines centralized benchmarking of GenAI models with the ISO/IEC 42001 certification of AI Management Systems (AIMS) implemented in healthcare organizations.

Date: 2024-08-13
New Economics Papers: this item is included in nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://osf.io/download/66bb8232968d7f053a2d3973/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:osf:osfxxx:vm6zy_v1

DOI: 10.31219/osf.io/vm6zy_v1

Access Statistics for this paper

More papers in OSF Preprints from Center for Open Science
Bibliographic data for series maintained by OSF ().